// App-Quantinova.ai

3628 : Increased Capacity Of Monocytes From Patients With Multiple Myeloma Treated With Thalidomide Or Lenalidomide To Generate Tissue Factor

Researchers

Presenter

  • Abraham Kornberg

Principal Investigators

  • Marina Izak

  • Yossi Cohen

Medical Centers

  • Hematology, Assaf Harofeh Hospital and Tel Aviv University, B-er Yacob, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Venous thrombosis

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 14

  • Coagulation Factor III, Tissue Factor

  • Thomsen-Friedenreich antigen

Drug/Treatment

  • Lenalidomide

  • Thalidomide

  • Bortezomib

  • Hypaque Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved